ABOUT

ISSUE

SUPPORT

PATIENT SAFETY

NEWSROOM

RESOURCES

GET INVOLVED

ABOUT

ISSUE

SUPPORT

PATIENT SAFETY

NEWSROOM

RESOURCES

ABOUT

ISSUE

SUPPORT

PATIENT SAFETY

NEWSROOM

RESOURCES

GET INVOLVED

Newsroom

Newsroom

Newsroom

ALL POSTS

PRESS RELEASES

Aug 24, 2026

Op-Ed: How The FDA’s Green List For GLP-1 Drugs Fuels The Gray Market Problem

Aug 5, 2026

Michigan Man Sentenced to 21 Months in Federal Peptide and GLP-1 Drug Case

Jun 7, 2026

Opinion: How risky can the weight-loss drug boom be? I learned the hard way.

Mar 26, 2026

Cotton Introduced Bill to End U.S. Dependence on Chinese-Manufactured Pharmaceuticals

ALL POSTS

PRESS RELEASES

Aug 24, 2026

Op-Ed: How The FDA’s Green List For GLP-1 Drugs Fuels The Gray Market Problem

Aug 5, 2026

Michigan Man Sentenced to 21 Months in Federal Peptide and GLP-1 Drug Case

Jun 7, 2026

Opinion: How risky can the weight-loss drug boom be? I learned the hard way.

Mar 26, 2026

Cotton Introduced Bill to End U.S. Dependence on Chinese-Manufactured Pharmaceuticals

RX Border Defense is a 501c4 nonprofit organization. 


ABOUT

ISSUE

PATIENT SAFETY

SUPPORT

GET INVLOVED

RX Border Defense is a 501c4 nonprofit organization. 


ABOUT

ISSUE

PATIENT SAFETY

SUPPORT

GET INVLOVED

RX Border Defense is a 501c4 nonprofit organization. 


ABOUT

ISSUE

PATIENT SAFETY

SUPPORT

GET INVLOVED